Effects of viral load on tenofovir vs.entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma  

作　　者：Weili Qi Junyi Shen Yu Zhang Fengwei Gao Chuan Li 

机构地区：[1]Department of Liver Surgery and Liver Transplantation Center,West China Hospital of Sichuan University,Chengdu,Sichuan 610041,China [2]Institute of Clinical Pathology,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China [3]Organ Transplantation Center,Sichuan Provincial People’s Hospital,Chengdu,Sichuan 610072,China [4]HBPS Diseases Center for Diagnosis and Treatment of Leshan City,People’s Hospital of Leshan,Leshan,Sichuan 614000,China

出　　处：《Chinese Medical Journal》2023年第19期2362-2364,共3页中华医学杂志（英文版）

基　　金：supported by grants from the National Natural Science Foundation of China(Nos.81900576,82100650);the Science and Technological Supports Project of Sichuan Province(Nos.2019YJ0149,22ZDYF1593);the Post-Doctor Research Project,West China Hospital,Sichuan University(No.2020HXBH069)

摘　　要：Serum hepatitis B virus deoxyribonucleic acid(HBVDNA)load is a critical index used to reflect the degree of viral replication in hepatocytes and to evaluate host hepatitis viral status.The risk of hepatocellular carcinoma(HCC)incidence or recurrence varies depending on whether the HBV-DNA load is high or low.[1]Consistent with previous studies and expert opinion,a HBV-DNA level>2000 IU/mL was defined as a high HBV-DNA load in the current study.

关 键 词：PREVENTION HEPATOCELLULAR load 

分 类 号：R735.7[医药卫生—肿瘤] R512.62[医药卫生—临床医学]